Effects of bevacizumab and capecitabine combined with intraperitoneal thermoperfusion chemotherapy on therapeutic effect, immunity and prognosis of gastric cancer patients

Minerva Med. 2022 Apr;113(2):358-359. doi: 10.23736/S0026-4806.21.07349-3. Epub 2021 Feb 8.

Authors

Kun Liu¹, Jing Xu¹, Baoyin Chen¹, Yunbo Bai², Zhufang Ma³

Affiliations

¹ Department of Gastroenterology, Hanzhong 3201 Hospital, Hanzhong, China.
² Department of Medical Oncology, Hanzhong 3201 Hospital, Hanzhong, China.
³ Department of Gastroenterology, Hanzhong 3201 Hospital, Hanzhong, China - 258131576@qq.com.

PMID: 33555164
DOI: 10.23736/S0026-4806.21.07349-3

No abstract available

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Bevacizumab / therapeutic use
Capecitabine / therapeutic use
Colorectal Neoplasms*
Humans
Prognosis
Stomach Neoplasms* / drug therapy

Substances

Bevacizumab
Capecitabine